Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porter’s Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Custom Antibody Market, by Service
6.1 Introduction
6.2 Antibody Development
6.2.1 Antibody Characterization
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.2 Antigen Preparation
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.2.3 Immunization & Hybridoma Production
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.3 Antibody Production & Purification
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
6.4 Antibody Fragmentation & Labeling
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 7. Global Custom Antibody Market, by Source
7.1 Introduction
7.2 Mice
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.3 Rabbits
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.4 Human beings
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
7.5 Other Sources
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 8. Global Custom Antibody Market, by Type
8.1 Introduction
8.2 Monoclonal Antibodies
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.3 Polyclonal Antibodies
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.4 Recombinant Antibodies
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
8.5 Other Custom Antibodies
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 9. Global Custom Antibody Market, by Research Area
9.1 Introduction
9.2 Oncology
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.3 Infectious Diseases
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.4 Immunology
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.5 Neurobiology
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.6 Stem Cells
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.7 Cardiovascular Diseases
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
9.8 Others
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 10. Global Custom Antibody Market, by End-Users
10.1 Introduction
10.2 Pharmaceutical & Biotechnology Companies
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
10.3 Hospitals and Clinics
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
10.4 Academic & Research Institutes
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
10.5 Contract Research Organizations
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
10.6 Others
Market Estimates & Forecast, by Region, 2023-2030
Market Estimates & Forecast, by Country, 2023-2030
Chapter 11. Global Custom Antibody Market, by Region
11.1 Introduction
11.2 Americas
11.2.1 North America
11.2.1.1 US
11.2.1.2 Canada
11.2.2 South America
11.3 Europe
11.3.1 Western Europe
11.3.1.1 Germany
11.3.1.2 France
11.3.1.3 Italy
11.3.1.4 Spain
11.3.1.5 UK
11.3.1.6 Rest of Western Europe
11.3.2 Eastern Europe
11.4 Asia-Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 South Korea
11.4.6 Rest of Asia-Pacific
11.5 Middle East & Africa
11.5.1 Middle East
11.5.2 Africa
Chapter 12. Company Landscape
12.1 Introduction
12.2 Market Share Analysis
12.3 Key Development & Strategies
Chapter 13. Company Profiles
13.1 Thermo Fisher Scientific Inc.
13.1.1 Company Overview
13.1.2 Product Overview
13.1.3 Financials Overview
13.1.4 Key Developments
13.1.5 SWOT Analysis
13.2 Genscript
13.2.1 Company Overview
13.2.2 Product Overview
13.2.3 Financial Overview
12.2.4 Key Developments
13.2.5 SWOT Analysis
13.3 Abcam PLC
13.3.1 Company Overview
13.3.2 Product Overview
13.3.3 Financial Overview
13.3.4 Key Development
13.3.5 SWOT Analysis
13.4 Merck Group
13.4.1 Company Overview
13.4.2 Technology/Business Segment Overview
13.4.3 Financial Overview
13.4.4 Key Development
13.4.5 SWOT Analysis
13.5 Bio-Rad Laboratories, Inc.
13.5.1 Company Overview
13.5.2 Product Overview
13.5.3 Financial overview
13.5.4 Key Developments
13.5.5 SWOT Analysis
13.6 Cell Signaling Technology, Inc.
13.6.1 Company Overview
13.6.2 Product Overview
13.6.3 Financial Overview
13.6.4 Key Developments
13.6.5 SWOT Analysis
13.7 Agilent Technologies, Inc.
13.7.1 Overview
13.7.2 Product Overview
13.7.3 Financial Overview
13.7.4 Key Developments
13.7.5 SWOT Analysis
13.8 Biolegend, Inc.
13.8.1 Overview
13.8.2 Service / Technology Overview
13.8.3 Financials
13.8.4 Key Developments
13.8.5 SWOT Analysis
13.9 Rockland Immunochemicals Inc.
13.9.1 Overview
13.9.2 Product Overview
13.9.3 Financials
13.9.4 Key Developments
13.9.5 SWOT Analysis
13.10 Promab Biotechnologies, Inc.
13.10.1 Overview
13.10.2 Product Overview
13.10.3 Financials
13.10.4 Key Developments
13.10.5 SWOT Analysis
13.11 Proteogenix
13.11.1 Overview
13.11.2 Product Overview
13.11.3 Financials
13.11.4 Key Developments
13.11.5 SWOT Analysis
13.12 Innovagen Ab
13.12.1 Overview
13.12.2 Product Overview
13.12.3 Financials
13.12.4 Key Developments
13.12.5 SWOT Analysis
Chapter 14 MRFR Conclusion
14.1 Key Findings
14.1.1 From CEO’s Viewpoint
14.1.2 Unmet Needs of the Market
14.2 Key Companies to Watch
14.3 Predictions for the Custom Antibody Industry
Chapter 15. Appendix
LIST OF TABLES
Table 1 Global Custom Antibody Market Synopsis, 2023-2030
Table 2 Global Custom Antibody Market Estimates and Forecast, 2023-2030 (USD Billion)
Table 3 Global Custom Antibody Market, by Region, 2023-2030 (USD Billion)
Table 4 Global Custom Antibody Market, by Service, 2023-2030 (USD Billion)
Table 5 Global Custom Antibody Market, by Source, 2023-2030 (USD Billion)
Table 6 Global Custom Antibody Market, by Type, 2023-2030 (USD Billion)
Table 7 Global Custom Antibody Market, by Research Area, 2023-2030 (USD Billion)
Table 8 Global Custom Antibody Market, by End-users, 2023-2030 (USD Billion)
Table 9 North America: Custom Antibody Market, by Service, 2023-2030 (USD
Billion)
Table 10 North America: Custom Antibody Market, by Source, 2023-2030 (USD Billion)
Table 11 North America: Custom Antibody Market, by Type, 2023-2030 (USD Billion)
Table 12 North America Custom Antibody Market, by Research Area, 2023-2030 (USD Billion)
Table 13 North America: Custom Antibody Market, by End-users, 2023-2030 (USD Billion)
Table 14 US: Custom Antibody Market, by Service, 2023-2030 (USD Billion)
Table 15 US: Custom Antibody Market, by Source, 2023-2030 (USD Billion)
Table 16 US: Custom Antibody Market, by Type, 2023-2030 (USD Billion)
Table 17 US: Custom Antibody Market, by Research Area, 2023-2030 (USD Billion)
Table 18 US: Custom Antibody Market, by End-users, 2023-2030 (USD Billion)
Table 19 Canada: Custom Antibody Market, by Service, 2023-2030 (USD Billion)
Table 20 Canada: Custom Antibody Market, by Source, 2023-2030 (USD Billion)
Table 21 Canada: Custom Antibody Market, by Type, 2023-2030 (USD Billion)
Table 22 Canada Custom Antibody Market, by Research Area, 2023-2030 (USD Billion)
Table 23 Canada: Custom Antibody Market, by End-users, 2023-2030 (USD Billion)
Table 24 South America: Custom Antibody Market, by Service, 2023-2030 (USD Billion)
Table 25 South America: Custom Antibody Market, by Source, 2023-2030 (USD Billion)
Table 26 South America: Custom Antibody Market, by Type, 2023-2030 (USD Billion)
Table 27 South America Custom Antibody Market, by Research Area, 2023-2030 (USD Billion)
Table 28 South America: Custom Antibody Market, by End-users, 2023-2030 (USD Billion)
Table 29 Europe: Custom Antibody Market, by Service, 2023-2030 (USD Billion)
Table 30 Europe: Custom Antibody Market, by Source, 2023-2030 (USD Billion)
Table 31 Europe: Custom Antibody Market, by Type, 2023-2030 (USD Billion)
Table 32 Europe Custom Antibody Market, by Research Area, 2023-2030 (USD Billion)
Table 33 Europe: Custom Antibody Market, by End-users, 2023-2030 (USD Billion)
Table 34 Western Europe: Custom Antibody Market, by Service, 2023-2030 (USD Billion)
Table 35 Western Europe: Custom Antibody Market, by Source, 2023-2030 (USD Billion)
Table 36 Western Europe: Custom Antibody Market, by Type, 2023-2030 (USD Billion)
Table 37 Western Europe Custom Antibody Market, by Research Area, 2023-2030 (USD Billion)
Table 38 Western Europe: Custom Antibody Market, by End-users, 2023-2030 (USD Billion)
Table 39 Eastern Europe: Custom Antibody Market, by Service, 2023-2030 (USD Billion)
Table 40 Eastern Europe Custom Antibody Market, by Source, 2023-2030 (USD Billion)
Table 41 Eastern Europe Custom Antibody Market, by Type, 2023-2030 (USD Billion)
Table 42 Eastern Europe Custom Antibody Market, by Research Area, 2023-2030 (USD Billion)
Table 43 Eastern Europe: Custom Antibody Market, by End-users, 2023-2030 (USD Billion)
Table 44 Asia-Pacific: Custom Antibody Market, by Service, 2023-2030 (USD Billion)
Table 45 Asia-Pacific: Custom Antibody Market, by Source, 2023-2030 (USD Billion)
Table 46 Asia-Pacific: Custom Antibody Market, by Type, 2023-2030 (USD Billion)
Table 47 Asia-Pacific Custom Antibody Market, by Research Area, 2023-2030 (USD Billion)
Table 48 Asia-Pacific: Custom Antibody Market, by End-users, 2023-2030 (USD Billion)
Table 49 Middle East & Africa: Custom Antibody Market, by Service, 2023-2030 (USD Billion)
Table 50 Middle East & Africa Custom Antibody Market, by Source, 2023-2030 (USD Billion)
Table 51 Middle East & Africa: Custom Antibody Market, by Type, 2023-2030 (USD Billion)
Table 52 Middle East & Africa Custom Antibody Market, by Research Area, 2023-2030 (USD Billion)
Table 53 Middle East & Africa: Custom Antibody Market, by End-users, 2023-2030 (USD Billion)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Custom Antibody Market
Figure 3 Segmentation Market Dynamics for Global Custom Antibody Market
Figure 4 Global Custom Antibody Market Share, by Service, 2022
Figure 5 Global Custom Antibody Market Share, by Source, 2022
Figure 6 Global Custom Antibody Market Share, by Type, 2022
Figure 7 Global Custom Antibody Market Share, by Research Area, 2022
Figure 8 Global Custom Antibody Market, by End-users, 2023-2030 (USD Billion)
Figure 9 Global Custom Antibody Market Share, by Region, 2022
Figure 10 North America: Custom Antibody Market Share, by Country, 2022
Figure 11 Europe: Custom Antibody Market Share, by Country, 2022
Figure 12 Asia-Pacific: Custom Antibody Market Share, by Country, 2022
Figure 13 Middle East & Africa: Custom Antibody Market Share, by Country, 2022
Figure 14 Global Custom Antibody Market: Company Share Analysis, 2022 (%)
Figure 15 Thermo Fisher Scientific Inc.: Key Financials
Figure 16 Thermo Fisher Scientific Inc.: Segmental Revenue
Figure 17 Thermo Fisher Scientific Inc.: Geographical Revenue
Figure 18 Genscript: Key Financials
Figure 19 Genscript: Segmental Revenue
Figure 20 Genscript: Geographical Revenue
Figure 21 Abcam PLC: Key Financials
Figure 22 Abcam PLC: Segmental Revenue
Figure 23 Abcam PLC: Geographical Revenue
Figure 24 Merck Group: Key Financials
Figure 25 Merck Group: Segmental Revenue
Figure 26 Merck Group: Geographical Revenue
Figure 27 Bio-Rad Laboratories, Inc.: Key Financials
Figure 28 Bio-Rad Laboratories, Inc.: Segmental Revenue
Figure 29 Bio-Rad Laboratories, Inc.: Geographical Revenue
Figure 30 Cell Signaling Technology, Inc.: Key Financials
Figure 31 Cell Signaling Technology, Inc.: Segmental Revenue
Figure 32 Cell Signaling Technology, Inc.: Geographical Revenue
Figure 33 Agilent Technologies, Inc.: Key Financials
Figure 34 Agilent Technologies, Inc.: Segmental Revenue
Figure 35 Agilent Technologies, Inc.: Geographical Revenue
Figure 36 Biolegend, Inc.: Key Financials
Figure 37 Biolegend, Inc.: Segmental Revenue
Figure 38 Biolegend, Inc.: Geographical Revenue
Figure 39 Rockland Immunochemicals Inc.: Key Financials
Figure 40 Rockland Immunochemicals Inc.: Segmental Revenue
Figure 41 Rockland Immunochemicals Inc.: Geographical Revenue
Figure 42 Promab Biotechnologies, Inc.: Key Financials
Figure 43 Promab Biotechnologies, Inc.: Segmental Revenue
Figure 44 Promab Biotechnologies, Inc.: Geographical Revenue
Figure 45 Proteogenix: Key Financials
Figure 46 Proteogenix: Segmental Revenue
Figure 47 Proteogenix: Geographical Revenue
Figure 48 Innovagen Ab: Key Financials
Figure 49 Innovagen Ab: Segmental Revenue
Figure 50 Innovagen Ab: Geographical Revenue
